Summary & Overview

HCPCS G8882: Sentinel Lymph Node Biopsy Not Performed, Reason Not Given

HCPCS Level II code G8882 documents that a sentinel lymph node biopsy was not performed and no reason for omission was provided. This administrative code matters nationally because accurate reporting of omitted procedures affects clinical documentation, quality measurement, surgical care pathways, and claims adjudication. Payers use this indicator to reconcile expected care with delivered services and to support audit and quality workflows.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an explanation of what G8882 represents, the clinical context for sentinel lymph node biopsy, and why noting a non-performed procedure is operationally important. The publication outlines typical sites of service and service type, common billing modifiers when available, and where G8882 fits within procedure reporting and quality reporting frameworks.

The content provides national-level benchmarks and policy context where available, highlights implications for claims processing and quality measurement, and summarizes documentation considerations. Data not available in the input is noted explicitly where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG8882HCPCS Level IIsentinel lymph node biopsysurgical documentationprocedure not performedclaims reportingquality measurementsurgical oncology

Billing Code Overview

HCPCS Level II code G8882 indicates that a sentinel lymph node biopsy procedure was not performed, reason not given. This code documents the absence of the sentinel lymph node biopsy during an episode of care when no specific reason for omission is reported.

Service type: Surgical diagnostic procedure not performed
Typical site of service: Hospital inpatient or outpatient surgical setting

Clinical & Coding Specifications

Clinical Context

A typical patient is a woman with newly diagnosed early-stage breast cancer scheduled for a sentinel lymph node biopsy (SLNB) at an ambulatory surgical center or hospital outpatient department. Preoperative workup includes imaging (mammography, ultrasound ± MRI), core needle biopsy confirming invasive carcinoma, and clinical nodal exam. On the day of surgery, after induction of anesthesia, lymphatic mapping with radiotracer and/or blue dye is planned. The operative team documents that the sentinel lymph node biopsy procedure was not performed due to an intraoperative determination such as unexpected extensive nodal involvement on palpation, inability to localize sentinel nodes after tracer/dye injection, significant anatomic distortion from prior surgery or radiation, patient instability requiring procedure abandonment, or conversion to a different nodal management strategy (for example, immediate axillary lymph node dissection). The anesthesia and surgical teams document the reason when known; if no reason is recorded in the chart, the billing code G8882 is used to indicate the SLNB was not performed and no specific rationale was provided. Usual sites of service include hospital outpatient departments and ambulatory surgical centers; the typical workflow includes preoperative consent, lymphatic mapping attempt, intraoperative evaluation, and documentation of non-performance with applicable modifiers appended to the claim as indicated by the clinical circumstances and payer rules.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	When work required is substantially greater than typically required for the SLNB attempt and payer accepts documentation for increased complexity.
`23`	Unusual anesthesia	When general anesthesia is required for conditions that typically do not require it during the attempted SLNB.
`52`	Reduced services	When the SLNB was begun but substantially reduced or incomplete (partial attempt) and payer allows partial service reporting.
`53`	Discontinued procedure	When the SLNB was started but then terminated due to extenuating circumstances or patient instability; used with operative notes documenting abandonment.
`54`	Surgical care only	When only the surgeon’s intraoperative portion is billed separate from pre/postoperative care (rare in SLNB non-performance scenarios).
`55`	Postoperative management only	When only postoperative care is billed by another provider following an SLNB-related encounter.
`56`	Preoperative management only	When only preoperative management is billed by a provider separate from the surgeon who would have performed the SLNB.
`62`	Two surgeons	When two surgeons were required for the attempted procedure prior to non-performance and both bill according to payer policy.
`AS`	Ambulatory surgical center facility component	When the service is provided in an ambulatory surgical center; appended per payer billing rules for facility identification.
`CO`	Worker’s compensation	When the procedure relates to worker’s compensation coverage; use per payer requirements.

Taxonomy Code	Specialty	Notes
`207Q00000X`	General Surgery	General surgeons commonly perform or attempt SLNB for breast and melanoma cases.
`207Y00000X`	Surgical Oncology	Surgical oncologists frequently perform SLNB in cancer staging workflows.
`207XX0004X`	Breast Surgery	Breast surgeons specialize in SLNB for breast cancer staging and management.
`208000000X`	Thoracic Surgery	Thoracic surgeons may perform SLNB for cutaneous or melanoma lesions of the chest and upper torso.
`363LF0000X`	Anesthesiology	Anesthesiologists provide perioperative anesthesia care for SLNB attempts and related conversions.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C50.911`	Malignant neoplasm of unspecified site of right female breast	Primary breast cancer is a common indication for SLNB to stage axillary nodes.
`C50.912`	Malignant neoplasm of unspecified site of left female breast	Used when left-sided breast cancer prompts SLNB for staging.
`C44.51`	Basal cell carcinoma of skin of face	Cutaneous cancers such as melanoma or certain high-risk nonmelanoma skin cancers may require SLNB when staging risk justifies it.
`C43.9`	Malignant melanoma of skin, unspecified	Melanoma is a common indication for SLNB to assess regional nodal metastasis.
`D05.90`	Lobular carcinoma in situ of breast, unspecified site	Certain high-risk in situ lesions may prompt sentinel node assessment in select clinical scenarios.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`38792`	Injection procedure for localization of lymphatic channels and/or sentinel nodes (eg, for sentinel node identification), including imaging when performed	Performed prior to or during SLNB to localize sentinel nodes; often attempted when `G8882` is reported because localization attempts failed.
`38795`	Surgical excision, open, of lymph node(s), deep axillary, radical, including removal of surrounding tissue (axillary lymph node dissection)	May be performed if SLNB cannot be completed and surgeon proceeds directly to axillary lymph node dissection intraoperatively.
`19307`	Mastectomy, modified radical (including axillary lymph nodes)	In cases where disease extent necessitates more extensive breast and nodal surgery, SLNB may be aborted and a modified radical procedure performed.
`38900`	Intraoperative identification of sentinel node(s) by mapping procedure (including injection of tracer and/or dye) when performed without excision	Related mapping technique that may be attempted; failure of this step can lead to reporting `G8882`.
`37241`	Vascular embolization or occlusion of vessel(s); therapeutic, radiologic supervision and interpretation	Occasionally used in complex preoperative or intraoperative hemostasis scenarios when bleeding complicates SLNB attempts; less commonly directly related but listed for multidisciplinary workflows.